| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/11/2012 | EP1750665B1 Biodegradable intravitreal tyrosine kinase inhibitors implants |
| 07/11/2012 | EP1740156B8 Method for the production of an abuse-proof, solid form of administration |
| 07/11/2012 | EP1715856B1 Atomoxetine formulations |
| 07/11/2012 | EP1615622B1 Once daily formulations of doxycyclines |
| 07/11/2012 | EP1494646B1 Intravaginal matrix drug delivery devices |
| 07/11/2012 | EP1467703B1 Method for treatment of a region of the skin of a human subject, in particular cosmetic treatment by the trans-epidermal route using projection of a liquid under pressure |
| 07/11/2012 | EP1397114B1 Aerosol composition comprising silicate particles and polymers |
| 07/11/2012 | EP1241949B1 Release of lipophilic active agents from chewing gum |
| 07/11/2012 | EP1131052B1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 07/11/2012 | CN202314492U 四物滴丸 Four things Dripping Pills |
| 07/11/2012 | CN202314491U 小儿镇静镇痛含服剂型 Pediatric sedation sublingual formulation |
| 07/11/2012 | CN202314490U Plaster convenient for tearing |
| 07/11/2012 | CN202314489U 一种治疗颈椎病的外用黑膏药贴 A treatment for cervical spondylosis topical patch to black |
| 07/11/2012 | CN202314488U 一种防过敏止痛贴膏 An anti-allergic and pain Plaster |
| 07/11/2012 | CN202314487U 一种新型的缓释胶囊 A new release capsules |
| 07/11/2012 | CN202314486U 一种治疗口臭的胶囊 A capsule in the treatment of bad breath |
| 07/11/2012 | CN202314485U 糖尿病康复胶囊 Diabetes Rehabilitation Capsules |
| 07/11/2012 | CN202314484U Rosiglitazone maleate gastrointestinal mini-tablet capsule |
| 07/11/2012 | CN202314483U Easily broken tablet |
| 07/11/2012 | CN202314482U 布洛芬定时释药三层片 The timing of release of ibuprofen three-piece |
| 07/11/2012 | CN202314481U 一种成人药片 One kind of adult tablet |
| 07/11/2012 | CN202314480U 一种改进型消风止痒颗粒 An improved particle Xiaofeng itching |
| 07/11/2012 | CN202314479U 通便栓 Laxative suppository |
| 07/11/2012 | CN1899593B Powder for treating common cold and its preparing method |
| 07/11/2012 | CN1839847B Tizanidine hydrochloride oral disintegrating tablet and preparation method thereof |
| 07/11/2012 | CN1805731B Composition and device for enhancing dosing efficiency |
| 07/11/2012 | CN1762381B Ophthalmic compositions containing galactomannan polymers and borate |
| 07/11/2012 | CN1686139B Application of ketosolin in new type analgesic for treatig inflammatory pain |
| 07/11/2012 | CN102574961A Hybrid copolymer compositions |
| 07/11/2012 | CN102573923A Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 07/11/2012 | CN102573914A Porphyrin nanovesicles |
| 07/11/2012 | CN102573913A Biodegradable polyethylene glycol based water-insoluble hydrogels |
| 07/11/2012 | CN102573912A Method for improving the aqueous solubility of poorly-soluble substances |
| 07/11/2012 | CN102573911A Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders |
| 07/11/2012 | CN102573886A Method of treating asthma with antiviral agents |
| 07/11/2012 | CN102573858A A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 07/11/2012 | CN102573843A Transdermally absorbable donepezil-containing preparation |
| 07/11/2012 | CN102573835A Film-coated tablet which is suppressed in discoloration and odor |
| 07/11/2012 | CN102573832A Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors |
| 07/11/2012 | CN102573821A Smoking cessation with body weight maintenance and nutritional supplement |
| 07/11/2012 | CN102573818A Biodegradable foams with improved dimensional stability |
| 07/11/2012 | CN102573817A Transdermal therapeutic systems containing 4-n-butylresorcinol |
| 07/11/2012 | CN102573816A Low ether composition and delivery apparatus |
| 07/11/2012 | CN102573815A Treatment and prevention of HIV infection |
| 07/11/2012 | CN102573814A Polymer vesicles of asymmetric membrane |
| 07/11/2012 | CN102573813A 持续药物传递系统 Sustained drug delivery system |
| 07/11/2012 | CN102573812A Scented capsules |
| 07/11/2012 | CN102573811A Sustained release dosage form |
| 07/11/2012 | CN102573810A Extended use medical device |
| 07/11/2012 | CN102573809A Crystallization method and bioavailability |
| 07/11/2012 | CN102573808A Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 07/11/2012 | CN102573807A Ferric citrate dosage forms |
| 07/11/2012 | CN102573806A Tamper-resistant dosage form for oxidation-sensitive opioids |
| 07/11/2012 | CN102573805A Hot-melt extruded controlled release dosage form |
| 07/11/2012 | CN102573804A Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application |
| 07/11/2012 | CN102573803A Solid dispersion comprising an anti-HIV agent |
| 07/11/2012 | CN102573802A Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| 07/11/2012 | CN102573801A Novel pharmaceutical formulations against drug misuse |
| 07/11/2012 | CN102573800A Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 07/11/2012 | CN102573799A Pharmaceutical composition containing medicament-containing fine particles and method for producing same |
| 07/11/2012 | CN102573798A Methods and compositions for improving gastrointestinal health |
| 07/11/2012 | CN102573797A Emulsion activatable by ultrasounds and method for producing same |
| 07/11/2012 | CN102573796A Oral liquid formulation comprising salbutamol and guaifenesin |
| 07/11/2012 | CN102573795A Liquid pharmaceutical compositions |
| 07/11/2012 | CN102573794A Cysteine for physiological injection |
| 07/11/2012 | CN102573793A Transdermal pharmaceutical preparations |
| 07/11/2012 | CN102573792A Stabilized liquid and lyophilized ADAMTS13 formulations |
| 07/11/2012 | CN102573791A Improved formulations |
| 07/11/2012 | CN102573790A Implantable device for production of interleukin-1 receptor antagonist |
| 07/11/2012 | CN102573789A Subcutaneous anti-HER2 antibody formulation |
| 07/11/2012 | CN102573788A Oral care compositions containing human recombinant interleukin-1 |
| 07/11/2012 | CN102573755A Method for producing preparations of substances with low solubility in water |
| 07/11/2012 | CN102573723A Adhesive patch |
| 07/11/2012 | CN102573722A A preparation method of adhesive patch and a device thereof |
| 07/11/2012 | CN102573715A An intrauterine system |
| 07/11/2012 | CN102573612A Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles |
| 07/11/2012 | CN102573517A Stable thickener formulations |
| 07/11/2012 | CN102559111A Styrene-series hot-melt pressure-sensitive adhesive and preparation method |
| 07/11/2012 | CN102558546A Polyethylene glycol glycyrrhetinic acid ester, composite drug-loaded micelle and preparation method and application thereof |
| 07/11/2012 | CN102558391A Vitamin E succinate-chitosan graft and preparation method and application thereof |
| 07/11/2012 | CN102558298A Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers |
| 07/11/2012 | CN102558235A Method for preparing arsanilic acid by diazotizing trimethoprim |
| 07/11/2012 | CN102558234A Method for preparing arsanilic acid preparation by diazotization of amino phenylarsonic acid |
| 07/11/2012 | CN102558154A Lansoprazole crystalline compound, enteric capsule thereof and preparation method of Lansoprazole crystalline compound |
| 07/11/2012 | CN102558114A Preparation method for vitamin C bulk pharmaceutical |
| 07/11/2012 | CN102558070A 用于预防hiv性传播的杀微生物嘧啶或三嗪 Hiv microbicides for the prevention of sexual transmission of pyrimidine or triazine |
| 07/11/2012 | CN102553499A Method for preparing microcapsules based on low-ester pectin and calcium ion gelatinization and application of microcapsules |
| 07/11/2012 | CN102552950A Production process of unstable chemical injection |
| 07/11/2012 | CN102552947A Cation microvesicle and preparation method thereof |
| 07/11/2012 | CN102552946A Double-mode imaging and medicine-loading integrated nano medicine carrier and preparation method thereof |
| 07/11/2012 | CN102552928A Double-stage targeted drug delivery system curing brain tumor and preparation method of same |
| 07/11/2012 | CN102552918A Stabilizer of lyophilized powder injection for azithromycin injection |
| 07/11/2012 | CN102552917A Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 07/11/2012 | CN102552916A New use of sodium salicylate |
| 07/11/2012 | CN102552906A Productive technology of intravenous injection human immunoglobulin |
| 07/11/2012 | CN102552888A Suppository for treating mammal endometritis |
| 07/11/2012 | CN102552886A Oral superoxide dismutase (SOD) capsules having anti-oxidation effect and preparation method thereof |
| 07/11/2012 | CN102552879A Composition of pulmonary surfactant extract and pulmonary surfactant-associated protein A, preparation method and pharmaceutical application thereof |
| 07/11/2012 | CN102552877A Health-care preparation for improving osteoporosis and increasing bone density and preparation method thereof |
| 07/11/2012 | CN102552875A Difunctional VEGFA acceptor fusion protein preparation |